R&D channel feed – Endpoints News

R&D channel feed

Novavax’s held-up approval package may signal warning for Covid vaccine makers

Last month

Secretive Chinese startup begins first-ever clinical trial of circular RNA therapy

Last month

Arvinas touts healthy volunteer data for Parkinson's disease PROTAC

Last month

Eli Lilly pays struggling Sangamo $18M upfront to tap gene therapy capsid

Last month

Roche plans Phase 3 for its latest Alzheimer’s drug attempt after unveiling more early data

Last month

Another TIGIT trial fails as BeiGene scraps Phase 3 drug

Last month

Novartis’ Chinook-originated kidney disease drug gets accelerated approval

Last month

Sarepta, Roche pause Elevidys trials in Europe following patient death

Last month

Edgewise's heart drug shows promise in Phase 2 trial

Last month

Axsome reports Phase 3 depression fail for Sunosi

2 months ago

Compass Therapeutics touts trial success in biliary tract cancer, but more data are needed

2 months ago

Gubra’s AbbVie-partnered amylin looks competitive with Zealand’s in early trial

2 months ago

Big ambitions at Merck and AstraZeneca — along with a few giant pitfalls — reshape top ranks of the R&D 15

2 months ago

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

2 months ago

Lilly claims Phase 2 win for siRNA approach to mixed dyslipidemia

2 months ago

Tenaya to lay off about one-third of staff, reveals heart gene therapy data

2 months ago

Vaxcyte's Phase 2 pneumococcal vaccine data disappoint Wall Street

2 months ago

Corcept shares soar after Phase 3 win in platinum-resistant ovarian cancer

2 months ago

Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy

2 months ago

AstraZeneca’s cholesterol pill is set for Phase 3, but lags behind Merck rival

2 months ago

Marks’ exit at FDA rattles an already teetering biotech industry

2 months ago

Lilly's heart disease drug could be dosed as little as once a year, study shows

2 months ago

Exclusive: Transcend notches Phase 2 win to treat PTSD, invigorating budding neuroplastogen class

2 months ago

BiomX’s phage therapy succeeds in Phase 2 diabetic bone infection study

2 months ago

First page Previous page 3 4 567 8 9 Next page Last page